Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : °øÁö»çÇ×
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [±â»ç][±â°í] »ìÃæÁ¦°è¶õ, À¯Çع°Áú »ý¸®´ëÀÇ ¼ÒºñÀÚ ½Ã°¢
³»   ¿ë

[±â°í] »ìÃæÁ¦°è¶õ, À¯Çع°Áú »ý¸®´ëÀÇ ¼ÒºñÀÚ ½Ã°¢

½Å±¤½Ä Àü ÀǾàǰÁ¤Ã¥¿¬±¸¼ÒÀå(º¸°ÇÇÐ ¹Ú»ç)
µ¥Àϸ®ÆÊ 2017-09-15 06:14:53
°è¶õ°ú »ý¸®´ë ¹®Á¦°¡ ½Ä¾àó Çö¾ÈÀ¸·Î ž´º½º·Î ¶ß°Å¿î Çö¾ÈÀÌ µÇ¾ú´Ù. ÇÏÁö¸¸ ¾öû³­ À̽´ÀÇ Å©±â¿¡ ºñÇÏ¿© ½Ä¾àóµµ ¼ÒºñÀÚµµ ¸¸Á·ÇÑ ÇØ°á¹æ¾ÈÀ» ãÁö ¸øÇÑ Ã¤ °¥µîÀº ºÒ¾ÈÁ¤ÇÑ ¼Ò°­±¹¸éÀ¸·Î µé¾î°£ µíÇÏ´Ù.

°è¶õ »ìÃæÁ¦ÀÇ ÇÙ½ÉÀº °è¶õ¿¡ °ËÃâµÇ¾î¼­´Â ¾È µÇ´Â »ìÃæÁ¦°¡ °ËÃâµÉ ¶§±îÁö À̸¦ »çÀü¿¡ ÀÎÁöÇÏÁöµµ °É·¯³»Áöµµ ¸øÇÑ ½Ä¾àóÀÇ ¹«´É°ú Çã¼úÇØÁø ÀÎÁõÁ¦µµ¿¡ ¼ÒºñÀÚ°¡ È­°¡ ³­ °ÍÀÌÁö¸¸ ±× ÇÙ½ÉÀ» ÈξÀ Å©°Ô ÁõÆø½ÃŲ ¼ÒÅëÀÇ ¹®Á¦°¡ ÀáÀçµÇ¾î ÀÖ´Ù.

¼ÒºñÀÚ´Â Á¦µµÀÇ ÇãÁ¡µµ ¹®Á¦Áö¸¸ »ìÃæÁ¦ °è¶õÀÌ °Ç°­¿¡ ÀÌ»óÀÌ ¾ø´Ù´Â ½Ä¾àóÀÇ ÇØ¸í¿¡ ´õ È­°¡³ª ÀÖ´Ù. ¼ÒºñÀÚ ÀÔÀå¿¡¼­´Â ±¹³»¿Ü¿¡¼­ ¸ðµÎ »ç¿ëÀÌ ±ÝÁö µÇ¾îÀÖ°í °ËÃâµÈ Á¦Ç°À» Æó±âÇϸ鼭µµ °Ç°­¿£ ÀÌ»óÀÌ ¾ø´Ù´Â ÇØ¸íÀÌ µÚ´ÊÀº ¹ß»­À¸·Î ºñÃÄÁö´Â °ÍÀÌ´Ù. ÇÏÁö¸¸ ½Ä¾àó ÀÔÀå¿¡¼­´Â Á¤ºÎÀÇ ¾ÈÀü ÇØ¸íÀ» ¹ÏÁö ¾Ê´Â ±¹¹ÎÀÇ Â¥ÁõÀÌ ¡®¾ÈÀüÈ÷½ºÅ׸®¡¯·Î ºñÃçÁö°í ÀÖ´Â µíÇÏ´Ù. ÀÌ·¯ÇÑ Á¤È²À¸·Î Á¤ºÎÇØ¸í°ú Ãà¼ÒµÈ »ý»ê·®¿¡µµ °è¶õ °ªÀº °è¼Ó Æø¶ôÇϰí ÀÖ´Ù´Â ¼Ò½ÄÀÌ´Ù.

¾ÈÀü ±âÁØÀº °Ç°­À¯ÇؼöÁغ¸´Ù ´õ ¾ö°ÝÇÏ°Ô ¼³Á¤µÇ¾ú´Ù´Â °Í, µû¶ó¼­ ÀϹÝÀûÀ¸·Î ¾ÈÀüÇÏÁö¸¸ °³ÀÎÂ÷°¡ ÀÖ°í ÀÓ½ÅºÎ¿Í °°ÀÌ Æ¯º°È÷ ¿¹¹ÎÇÑ °æ¿ì°¡ ÀÖÀ» ¼ö ÀÖÀ½ÀÌ »ó¼¼È÷ ¼³¸íµÇÁö ¸øÇÏ¿´´Ù. ¶ÇÇÑ ¼ÒºñÀÚÀÇ °Ç°­À̽´ ¿Ü¿¡ Áß¿äÇÑ À̽´ÀΠȯ°æ ¿µÇâ Ãø¸é¿¡¼­ ´©ÀûµÇ´Â È­Çй°ÁúÀÌ º¸´Ù ¾ö°ÝÈ÷ °É·¯Á®¾ß ÇÏ´Â Ãø¸é¿ª½Ã ¼³¸íµÇÁö ¸øÇÏ¿´´Ù. DDT¹®Á¦°¡ Áï°¢ ´ëµÎµÇ¾úÁö¸¸ ȯ°æ¿¡ ¹ÌÄ¡´Â ¾Ç¿µÇâÀº ´©ÀûÀûÀÌ°í ºÒ°¡¿ªÀûÀÎ ¹®Á¦¿©¼­ ¾ÈÀü±âÁØÀº ÀÌ·± Á¡ÀÌ °í·ÁµÇ¾î ¼³Á¤µÈ °ÍÀÓÀ» »ó¼¼È÷ ¼³¸íÇÒ Çʿ䰡 ÀÖ¾ú´Ù.

°è¶õ¹®Á¦°¡ °¡¶ó¾É±âµµ Àü¿¡ ÅÍÁø »ý¸®´ë À¯ÇؼººÐ ¹®Á¦¿¡´Â ¼ÒºñÇÏ´Â Àΰ£ÀÇ °üÁ¡¿¡ Ãæ½ÇÇÏÁö ¸øÇÑ °ü·áÈ­µÈ Á¦µµÀÇ ÇãÁ¡ÀÌ °³ÀçµÇ¾î ÀÖ´Ù. Á¤ºÎÀÇ ÀÔÀå¿¡¼­ Á¦Ç°ÀÌ Àΰ£¿¡°Ô ¾î¶² ¹æ½ÄÀ¸·Î ¾î¶»°Ô ¿µÇâÀ» ¹ÌÄ¡´Â°¡ º¸´Ù´Â À̰ÍÀÇ Á¦µµÀû ±ÔÁ¦Á¶°Ç, Áï ºÐ·ùµÈ Á¦Ç°ÀÌ °ø»êǰ, ȤÀº »ýȰȭÇÐÁ¦Ç°ÀÎÁö ÀǾà¿ÜǰÀÎÁö È­ÀåǰÀÎÁö¸¦ ¸ÕÀú ÀüÁ¦ÇÏ¿© Á¢±ÙÇÑ´Ù.

Á¦µµ¿Í ±ÔÁ¦´Â Àΰ£ÀÇ ¼¶¼¼ÇÏ°í ´Ù¾çÇÑ »ç¿ë ȯ°æÀ» ´Ù ¹Ý¿µÇÏÁö ¸øÇÑ´Ù. »ý¸®´ë´Â ÀǾàǰó·³ ¸Ô´Â Á¦Ç°ÀÌ ¾Æ´Ï°í °¡½À±â »ì±ÕÁ¦Ã³·³ ÈíÀÔÇÏ´Â Á¦Ç°ÀÌ ¾Æ´Ï´Ù. ¶ÇÇÑ ±âÀú±Í³ª ¹Ýâ°í, ÆÒƼ¶óÀÌ³Ê µî°ú ´Þ¸® Ãë±ÞµÇ¾î¾ß ÇÒ Á¦µµÀû ÀÌÀ¯°¡ ¾ø¾î º¸ÀδÙ.

Çö´ëÀÇ °íµµÈ­µÈ Á¦Ç°Àº ÁÖ¼ÒÀçÀÇ ¿ø·á¿Í ¿ÏÀüÇÑ ¹ÐÆó, Èí½À¼º µîÀÇ ±â´ÉÀ» Áß½ÉÀ¸·Î °³¹ßµÇ°í ÀÖ´Ù. ÀÌ·¯ÇÑ ½ÅÁ¦Ç°Àº ¿ª¼³ÀûÀ¸·Î À¯ÇØÈ­Çй°ÀÌ ¹ß»ýÇÑ´Ù¸é ±×°ÍÀÌ ¿ÜºÎ·Î ¹ß»êµÉ ¼ö ¾øµµ·Ï ÇÏ°í ¹ÐÆóµÈ ³»ºÎÀÇ ½À¼º, Ç÷¾× ȯ°æÀº ¸¶Ä¡ ¿¬°í¸¦ ¹Ù¸¥ °Íó·³ ÇǺθ¦ ÅëÇØ Èí¼öµÉ À§ÇèÀ» Ű¿ü°í ÀÎÁ¢ÇÑ »ý½Ä ±â°üÀº È­Çй°Áú¿¡ °¡Àå ¹Î°¨ÇÑ °÷ÀÌ´Ù.

½Ä¾àó´Â ÆÑÆ®¸¦ µå·¯³»´Â °ÍÀÌ Á¦ ¿ªÇÒÀ̶ó°í »ý°¢ÇÒ ¼ö ÀÖ´Ù. ÇÏÁö¸¸ ±¹¹ÎÀº ½Ä¾àó°¡ ÆÑÆ®¸¦ µå·¯³»´Â Á¶»ç±â°üÀ̳ª ¹ýÀû ±ÔÁ¦±â°üÀ» ³Ñ¾î¼­ Àΰ£ÀÇ Á¦Ç° »ç¿ëÀ» ¼¶¼¼ÇÏ°í ¸é¹ÐÈ÷ º¸»ìÇÇ°í ¼±Á¦ÀûÀ¸·Î ´ëÀÀÇϵµ·Ï, À̽´¸¦ »ó¼¼È÷ ³³µæ°¡´ÉÇÏ°Ô ¼³¸íÇϵµ·Ï ¿ä±¸Çϰí ÀÖ°í »ç¿ëÀÚÀÇ ¾ÈÀü»ç¿ë ±Ô¹üÀ» Á¦½ÃÇØÁÙ °ÍÀ» ¿ä±¸Çϰí ÀÖ´Ù. ÀÌ·¯ÇÑ ¿ä±¸¸¦ »¡¸® ÀνÄÇϰí Á¦ ¿ªÇÒÀ» ´ÙÇÒ ¼ö ÀÖ´Â ½Ä¾àó·Î °Åµì³ª¾ß ÇÑ´Ù. ¸¸ÀÏ »ìÃæÁ¦ °è¶õ°ú »ý¸®´ë »çŸ¦ ÀÌ·¯ÇÑ ±â´ÉÀ» Á¤¸³ÇÏ´Â °è±â·Î »ïÀ» ¼ö ÀÖ´Ù¸é ½Ä¾àóÀÇ ´ëÀÀÀÌ ¾ÆÁÖ ´Ê±â¸¸ ÇÑ °ÍÀº ¾Æ´Ò ¼öµµ ÀÖ´Ù.

 

 

Ãâó : http://www.dailypharm.com/Users//News/NewsView.html?ID=230898

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
123 [±â»ç]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò °á»ê ÀÚü°¨»ç ¼ö°¨ °ü¸®ÀÚ 2018-02-19 1330
122 [±â»ç]¾à±¹, '°í°´»ó´ã ±â¹ý ¡¤ ÀÏ¹Ý¾à ±³À°' °æ¿µ°³¼± À§ÇØ °¡Àå ÇÊ¿ä °ü¸®ÀÚ 2018-02-19 1564
121 [±â»ç]ÀÏ»ó¿¡ ÁöÄ£ ¾à»çµé, ³ª¸¸ÀÇ Ãë¹Ì¿¡ ºüÁ®º¸¶ó °ü¸®ÀÚ 2018-02-05 1333
120 [±â»ç]°è¼ÓµÇ´Â °ø°ø½É¾ß¾à±¹ °³¼³¡¦À̹ø¿£ ¾È¾ç¡¤È­¼º °ü¸®ÀÚ 2018-02-02 1773
119 [±â»ç]Á¶Á¦ °³³ä, Àü¹®¼º¿¡ ¸Â°Ô ¹Ù²ã¾ß °ü¸®ÀÚ 2018-01-31 1491
118 [±â»ç]ȸ¿øÀÌ Áñ±â´Â ¸ð¹ÙÀÏ È¨ÆäÀÌÁö ±¸Ãà °ü¸®ÀÚ 2018-01-30 1427
117 ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ±è´ë¿ø ¼ÒÀå ½Å³â»ç ±è´ë¿ø 2018-01-05 1591
116 [±â»ç][Ä®·³] ÀǾàǰ ¾ÈÀü»ç¿ë±³À°ÀÇ ¼º°ú¿Í °úÁ¦ °ü¸®ÀÚ 2017-12-27 1579
115 [±â»ç]¾î¸°ÀÌ ´Ùºóµµ Áúȯ¡¤ÀǾàǰ Á¤º¸, Á÷Á¢ È®ÀÎÇØº¸¼¼¿ä °ü¸®ÀÚ 2017-11-27 1713
114 [±â»ç][±â°í] »ìÃæÁ¦°è¶õ, À¯Çع°Áú »ý¸®´ëÀÇ ¼ÒºñÀÚ ½Ã°¢ °ü¸®ÀÚ 2017-09-15 1891
113 [±â»ç]"°æ±â ½É¾ß°ø°ø¾à±¹ ÀûÇÕ"...°³Àξ౹¡¤24½Ã°£ ¼­ºñ½ºÇü Á¢±Ù °ü¸®ÀÚ 2017-09-07 2114
112 [±â»ç]½É¾ß¾à±¹ µµÀÔ...¾à°è "Ãë¾à½Ã°£´ë º¸¿Ï" vs Á¤ºÎ "ÀçÁ¤ ºÎ´ã" °ü¸®ÀÚ 2017-09-07 2068
111 [±â»ç]¼­¸é¹æ½Ä Çã¿ë, ¾à»ç Àνĺ¯È­¿¡ ±àÁ¤Àû ¿µÇâ °ü¸®ÀÚ 2017-08-29 2255
110 [±â»ç]ÀǾàǰÁ¤Ã¥ ¿¬±¸¼Ò, »ó¹Ý±â ÀÚü°¨»ç ¼ö°¨ °ü¸®ÀÚ 2017-08-16 1518
109 [±â»ç]¾à»ç Á÷´É ¹Ì·¡ Á¸¸³ÀÇ ÇØ¹ýÀº 'ȯÀÚ¿ÍÀÇ ¼ÒÅë' °ü¸®ÀÚ 2017-07-12 1884

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»